{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:15:13Z","timestamp":1786976113102,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd011006","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000}}],"reference-count":142,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011006.pub2","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:55:44Z","timestamp":1433206544000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antidepressants for the treatment of depression in people with cancer"],"prefix":"10.1002","author":[{"given":"Giovanni","family":"Ostuzzi","sequence":"first","affiliation":[{"name":"University of Verona; \u200bDepartment of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry; Policlinico \"GB Rossi\" Piazzale L.A. Scuro, 10 Verona Italy 37134"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Matcham","sequence":"additional","affiliation":[{"name":"The Institute of Psychiatry, King's College London; Department of Psychological Medicine; Weston Education Centre London UK SE5 9RJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dauchy","sequence":"additional","affiliation":[{"name":"Gustave Roussy; Chef du D\u00e9partement Interdisciplinaire de Soins de Support; 114 rue Edouard Vaillant Villejuif Paris France 94805"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Barbui","sequence":"additional","affiliation":[{"name":"University of Verona; Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry; Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hotopf","sequence":"additional","affiliation":[{"name":"The Institute of Psychiatry, King's College London; Department of Psychological Medicine; Weston Education Centre London UK SE5 9RJ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"issue":"Suppl 320","key":"10.1002\/14651858.CD011006.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0447.1985.tb08081.x","article-title":"Efficacy and safety of mianserin in the treatment of depression of women with cancer","volume":"72","author":"Costa","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0002|cit2","unstructured":"Dauchy S Saltel P Rey A Consoli SC Dolbeault S Razavi D A randomized, double-blind, placebo-controlled trial of escitalopram for the treatment of emotional distress during treatment for head and neck cancer International Clinical Trials Registry Platform 2014"},{"issue":"10","key":"10.1002\/14651858.CD011006.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1200\/JCO.2003.08.025","article-title":"Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group","volume":"21","author":"Fisch","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"291-300","DOI":"10.1002\/(SICI)1099-1611(199807\/08)7:4<291::AID-PON361>3.0.CO;2-U","article-title":"A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer","volume":"7","author":"Holland","year":"1998","journal-title":"Psycho-oncology"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4088\/JCP.v67n0217","article-title":"A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression","volume":"67","author":"Musselman","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"197-201","DOI":"10.1007\/s10549-007-9841-z","article-title":"Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy","volume":"112","author":"Navari","year":"2008","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1012518831494","article-title":"Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline","volume":"70","author":"Pezzella","year":"2001","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-0447.1996.tb09850.x","article-title":"The effect of fluoxetine on anxiety and depression symptoms in cancer patients","volume":"94","author":"Razavi","year":"1996","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.169.4.440","article-title":"Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin","volume":"69","author":"Heeringen","year":"1996","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"375-84","DOI":"10.1007\/s00520-011-1118-8","article-title":"Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study","volume":"20","author":"Amodeo","year":"2012","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.maturitas.2005.01.001","article-title":"Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors","volume":"52","author":"Biglia","year":"2005","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011006.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0378-5122(09)70131-8","article-title":"Duloxetine and escitalopram for treatment of hot flushes in breast cancer survivors","volume":"63","author":"Biglia","year":"2009","journal-title":"Maturitas"},{"issue":"29","key":"10.1002\/14651858.CD011006.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"3862","DOI":"10.1200\/JCO.2010.33.1298","article-title":"Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"Boekhout","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011006.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"S317","DOI":"10.1002\/pon.1594","article-title":"Algorithm-based treatment for depression in cancer outpatients: efficacy and tolerability evaluation of newer antidepressants","volume":"18","author":"Caldera","year":"2009","journal-title":"Psycho-oncology"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00520-008-0425-1","article-title":"Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine","volume":"16","author":"Cankurtaran","year":"2008","journal-title":"Supportive Care in Cancer"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD011006.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011006.pub2-BIB0018|cit18","first-page":"1","article-title":"Amitriptilin as coanalgesic in cancerous patients","volume":"13","author":"Carmen","year":"1990","journal-title":"Salud Mental"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/JGP.0b013e3181cc0350","article-title":"Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials","volume":"18","author":"Ell","year":"2010","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00006842-198801000-00009","article-title":"Treatment of depression in cancer patients is associated with better life adaptation: a pilot study","volume":"50","author":"Evans","year":"1988","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"254-6","DOI":"10.1097\/MJT.0b013e318187de2c","article-title":"The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment","volume":"20","author":"Heras","year":"2013","journal-title":"American Journal of Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011006.pub2-BIB0022|cit22","first-page":"432","article-title":"Investigation and intervening therapy to depression of malignant hematological diseases Baixuebing, Linbaliu","volume":"18","author":"Hua","year":"2009","journal-title":"Baixuebing, Linbaliu [Journal of Leukaemia and Lymphoma]"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0023|cit23","unstructured":"Montgomery C (contact name) A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia International Standard Randomised Controlled Trial Number Register 2003 10.1186\/ISRCTN51232664"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0024|cit24","unstructured":"Ozaki N (principal investigator) A study in the effects of sertraline on depressive symptoms of patients with inoperable advanced pancreatic cancer University Hospital Medical Information Network (UMIN) Center - Controlled Trials Register 2010"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(95)00138-7","article-title":"Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer","volume":"64","author":"Kalso","year":"1996","journal-title":"Pain"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011006.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"s269","DOI":"10.1002\/pon.1776","article-title":"A randomized, double-blind placebo-controlled study evaluating the efficacy of Lovaza (omega-3-acid-ethyl esters) compared to placebo for the treatment of depressive and anxiety symptoms in patients with breast cancer","volume":"19","author":"Kamath","year":"2010","journal-title":"Psycho-oncology"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpainsymman.2007.02.043","article-title":"Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms","volume":"35","author":"Kautio","year":"2008","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0028|cit28","unstructured":"Kim J Kim S Effects of bupropion and escitalopram for depression in cancer patients International Clinical Trials Registry Platform 2011"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1075-122X.2006.00218.x","article-title":"Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen","volume":"12","author":"Kimmick","year":"2006","journal-title":"The Breast Journal"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"689-93","DOI":"10.1093\/annonc\/mdl478","article-title":"Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients-a double-blind, randomized study","volume":"18","author":"Loibl","year":"2007","journal-title":"Annals of Oncology"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/archotol.134.5.528","article-title":"A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer","volume":"134","author":"Lydiatt","year":"2008","journal-title":"Otolaryngology--Head and Neck Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0032|cit32","first-page":"95","article-title":"Pharmacological correction of emotional status in breast cancer patients in the postoperative period","volume":"59","author":"Marasanov","year":"2013","journal-title":"\u0412\u041e\u041f\u0420\u041e\u0421\u042b \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0438 (Oncology Questions)"},{"issue":"24","key":"10.1002\/14651858.CD011006.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1200\/JCO.2003.04.070","article-title":"Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program","volume":"21","author":"Morrow","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD011006.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/npp.2013.85","article-title":"The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings","volume":"38","author":"Musselman","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0035|cit35","unstructured":"Straus DJ St. John's Wort in relieving fatigue in patients undergoing chemotherapy or hormone therapy for cancer ClinicalTrials.gov 2000"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0036|cit36","unstructured":"Ganzini LK Methylphenidate for depressed cancer patients receiving palliative care ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0037|cit37","unstructured":"Mago R Wellbutrin XL, major depressive disorder and breast cancer ClinicalTrial.gov 2005"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0038|cit38","unstructured":"Musselman DL Lawson D Miller A Evaluating the effectiveness of escitalopram in preventing or reducing depressive symptoms in people receiving interleukin-2 treatment ClinicalTrials.gov 2006"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0039|cit39","unstructured":"Dalal S Effects of mirtazapine on appetite in advanced cancer patients ClinicalTrials.gov 2007"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0040|cit40","unstructured":"Burke WJ Evaluating the effectiveness of escitalopram to prevent depression in head and neck cancer patients receiving treatment (PROTECT) ClinicalTrials.gov 2007"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0041|cit41","unstructured":"Verschraegen C Phase II study of Remeron for cancer patients losing more than 10% of their body weight ClinicalTrials.gov 2009"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0042|cit42","unstructured":"Rosenthal DI Symptom burden in head and neck cancer ClinicalTrials.gov 2010"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0043|cit43","unstructured":"He JC (study chair) Intervention study of depression in breast cancer patients ClinicalTrial.gov 2010"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0044|cit44","unstructured":"Waqar S Megestrol acetate with or without mirtazapine in treating cancer patients with weight loss or loss of appetite ClinicalTrials.gov 2011"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0045|cit45","unstructured":"Park E Pilot study to evaluate individualized choice of antidepressants in patients with cancer ClinicalTrials.gov 2012"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.euroneuro.2014.01.016","article-title":"Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study","volume":"24","author":"Ng","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jpainsymman.2012.06.011","article-title":"Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial","volume":"45","author":"Nunez","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"10.1002\/14651858.CD011006.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.sleep.2012.06.001","article-title":"Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program","volume":"13","author":"Palesh","year":"2012","journal-title":"Sleep Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1990.tb01584.x","article-title":"A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain","volume":"82","author":"Panerai","year":"1990","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD011006.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/pon.1800","article-title":"Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial","volume":"20","author":"Rodr\u00edguez Vega","year":"2011","journal-title":"Psycho-oncology"},{"issue":"3","key":"10.1002\/14651858.CD011006.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-004-2175-1","article-title":"Effect of paroxetine hydrochloride (Paxil\u00f2) on fatigue and depression in breast cancer patients receiving chemotherapy","volume":"89","author":"Roscoe","year":"2005","journal-title":"Breast Cancer Research and Treatment"},{"issue":"7","key":"10.1002\/14651858.CD011006.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1470-2045(07)70148-1","article-title":"Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression:a placebo-controlled double-blind randomised trial","volume":"8","author":"Stockler","year":"2007","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011006.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.intimp.2013.09.020","article-title":"Sertraline decreases serum level of interleukin-6 (IL-6) in haemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial","volume":"17","author":"Taraz","year":"2013","journal-title":"International Immunopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0885-3924(02)00381-0","article-title":"An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms","volume":"23","author":"Theobald","year":"2002","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0924-977X(97)88616-6","article-title":"Citalopram in the treatment of depression in patients suffering from simultaneous serious somatic disorders","volume":"7","author":"Tondlova","year":"1997","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0056|cit56","article-title":"Citalopram and dosulepine in adjuvant treatment\u2028 of oncological pain","volume":"4","author":"Tondlova\u0301","year":"2002","journal-title":"Bolest"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0057|cit57","unstructured":"UK Co-ordinating Committee on Cancer Research (UKCCCR) Neuropathic Pain Trial I: a national randomised trial of amitriptyline versus placebo controlled-trials.com 2007"},{"issue":"7","key":"10.1002\/14651858.CD011006.pub2-BIB0058|cit58","first-page":"482","article-title":"Paroxetine in treatment of cancer patients with anxiety and depression","volume":"17","author":"Zhang","year":"2003","journal-title":"Zhongguo zin li wei sheng za zhi (Chinese Mental Health Journal)"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3781\/j.issn.1000-7431.2011.05.015","article-title":"Preliminary study of association between breast cancer and depression","volume":"31","author":"Zhang","year":"2011","journal-title":"Tumor"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0060|cit60","first-page":"31","article-title":"Pharmacological correction of psychoemotional states of patients with thyroid nodules in the preoperative period","volume":"3c","author":"Zvukova","year":"2011","journal-title":"Russian Journal of Medicine"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0061|cit61","unstructured":"Rankin E Randomised double-blind placebo controlled trial of venlafaxine in recently diagnosed lung cancer patients: effects on symptom profiles after 12 weeks controlled-trials.com 2003"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0062|cit62","unstructured":"Miller AA Shaw EG Sertraline compared with Hypericum perforatum (St.John's Wort) in treating depression ClinicalTrials.gov 2013"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0063|cit63","unstructured":"Pirl W Escitalopram in treating depression in patients with advanced lung or gastrointestinal cancer ClinicalTrials.gov 2012"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0064|cit64","unstructured":"Nishimura R Matsushita M An randomized comparative study of efficacy and safety between mirtazapine and duloxetine hydrochloride in patients with cancer UMIN Clinical Trials Registry 2012"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0065|cit65","doi-asserted-by":"crossref","unstructured":"Yi Ba Mirtazapine plus gemcitabine versus gemcitabine in metastasis pancreatic cancer ClincalTrials.gov 2012","DOI":"10.1016\/j.ysur.2011.08.015"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005537.pub2","article-title":"Psychotherapy for depression among incurable cancer patients","author":"Akechi","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7066","key":"10.1002\/14651858.CD011006.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026988110001400101","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines","volume":"14","author":"Anderson","year":"2000","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD011006.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"e1156","DOI":"10.4088\/JCP.12f08054","article-title":"Breast cancer and antidepressant use","volume":"73","author":"Andrade","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0071|cit71","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0072|cit72","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0073|cit73","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1245\/s10434-012-2793-5","article-title":"Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer","volume":"20","author":"Arrieta","year":"2013","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1192\/bjp.178.2.129","article-title":"Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials","volume":"178","author":"Barbui","year":"2001","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.bp.109.076448","article-title":"Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis","volume":"198","author":"Barbui","year":"2011","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1017\/S1478951512000909","article-title":"Depressed patients with incurable cancer: which depressive symptoms do they experience?","volume":"11","author":"Brenne","year":"2013","journal-title":"Palliative and Supportive Care"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jclinepi.2005.11.010","article-title":"Single data extraction generated more errors than double data extraction in systematic reviews","volume":"59","author":"Buscemi","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/j.2051-5545.2011.tb00003.x","article-title":"Adjustment disorders: the state of the art","volume":"10","author":"Casey","year":"2011","journal-title":"World Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella","year":"1993","journal-title":"Journal of Clinical Oncology"},{"issue":"344","key":"10.1002\/14651858.CD011006.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"d8013","DOI":"10.1136\/bmj.d8013","article-title":"Out of sight but not out of mind: how to search for unpublished clinical trial evidence","volume":"3","author":"Chan","year":"2012","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"746-58","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"issue":"9238","key":"10.1002\/14651858.CD011006.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0140-6736(00)02821-X","article-title":"Depression and degree of acceptance of adjuvant cytotoxic drugs","volume":"356","author":"Colleoni","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007064.pub2","article-title":"Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients","author":"Galway","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"13","key":"10.1002\/14651858.CD011006.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/djs256","article-title":"Meta-Analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer","volume":"104","author":"Hart","year":"2012","journal-title":"Journal of the National Cancer Institute"},{"issue":"6974","key":"10.1002\/14651858.CD011006.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.310.6974.221","article-title":"Relative mortality from overdose of antidepressants","volume":"310","author":"Henry","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(11)60095-0","article-title":"Novel melatonin-based therapies: potential advances in the treatment of major depression","volume":"378","author":"Hickie","year":"2011","journal-title":"Lancet"},{"issue":"7414","key":"10.1002\/14651858.CD011006.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0093|cit93","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2753.2008.00986.x","article-title":"Interpretation of tests of heterogeneity and bias in meta-analysis","volume":"14","author":"Ioannidis","year":"2008","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YIC.0b013e328340775e","article-title":"Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials","volume":"26","author":"Iovieno","year":"2011","journal-title":"International Clinical Psychopharmacology"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11920-013-0404-1","article-title":"Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes","volume":"15","author":"Irwin","year":"2013","journal-title":"Current Psychiatry Reports"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-0327(81)90036-7","article-title":"Relationship of depression to medical illness. A critical review","volume":"3","author":"Kathol","year":"1981","journal-title":"Journal of Affective Disorders"},{"issue":"c693","key":"10.1002\/14651858.CD011006.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.c693","article-title":"Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study","volume":"340","author":"Kelly","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/pon.1576","article-title":"Quality of life of family caregivers at 2 years after a relative's cancer diagnosis","volume":"19","author":"Kim","year":"2010","journal-title":"Psycho-oncology"},{"issue":"140","key":"10.1002\/14651858.CD011006.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-13-140","article-title":"Antidepressants in the treatment of depression\/depressive symptoms in cancer patients: a systematic review and meta-analysis","volume":"13","author":"Laoutidis","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2147\/NDT.S36689","article-title":"Novel glutamatergic drugs for the treatment of mood disorders","volume":"9","author":"Lapidus","year":"2013","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1200\/JCO.2011.39.7372","article-title":"Evidence-based treatment of depression in patients with cancer","volume":"30","author":"Li","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2008.04.002","article-title":"Depression - an independent predictor of early death inpatients with advanced cancer","volume":"113","author":"Lloyd-Williams","year":"2009","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1002\/14651858.CD011006.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1177\/0269881112458732","article-title":"Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects","volume":"26","author":"Lopresti","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003491.pub2","article-title":"Antidepressants for depressed elderly","author":"Mottram","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.07.034","article-title":"The prevalence and pharmacotherapy of depression in cancer patients","volume":"131","author":"Ng","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0109|cit109","unstructured":"National Institute for Health & Clinical Excellence (NICE) Depression in adults with a chronic physical health problem. Treatment and management [CG91] National Clinical Practice Guideline 2009"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.genhosppsych.2006.05.006","article-title":"Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site","volume":"28","author":"Onitilo","year":"2006","journal-title":"General Hospital Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/537265","article-title":"Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication","volume":"2013","author":"Pilar-Cu\u00e9llar","year":"2013","journal-title":"Neural Plasticity"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1017\/S0033291709992285","article-title":"Depression and cancer mortality: a meta-analysis","volume":"40","author":"Pinquart","year":"2010","journal-title":"Psychological Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011006.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1200\/JCO.2002.07.101","article-title":"Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation","volume":"20","author":"Prieto","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD011006.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"283-94","DOI":"10.1016\/S0006-3223(03)00413-X","article-title":"Depression in cancer: new developments regarding diagnosis and treatment","volume":"54","author":"Raison","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011006.pub2-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007503.pub2","article-title":"Antidepressants for depression in physically ill people","author":"Rayner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0269216310380764","article-title":"Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis","volume":"25","author":"Rayner","year":"2011","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ejca.2010.11.027","article-title":"The development of evidence-based European guidelines on the management of depression in palliative cancer care","volume":"47","author":"Rayner","year":"2011","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.genhosppsych.2014.05.010","article-title":"Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis","volume":"36","author":"Riblet","year":"2014","journal-title":"General Hospital Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00520-006-0145-3","article-title":"The treatment of depression in cancer patients: a systematic review","volume":"15","author":"Rodin","year":"2007","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011006.pub2-BIB0121|cit121","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006932.pub2","article-title":"Pharmacological treatment of depression in patients with a primary brain tumour","author":"Rooney","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0122|cit122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006932.pub3","article-title":"Pharmacological treatment of depression in patients with a primary brain tumour","author":"Rooney","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.psyneuen.2013.10.008","article-title":"Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression","volume":"39","author":"Sarubin","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients. A meta-analysis","volume":"22","author":"Satin","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD011006.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2006.12.005","article-title":"The molecular neurobiology of depression","volume":"30","author":"Shelton","year":"2007","journal-title":"Psychiatric Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD011006.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2190\/PM.43.4.g","article-title":"Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea","volume":"43","author":"Shim","year":"2012","journal-title":"International Journal of Psychiatry in Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1017\/S0033291799001324","article-title":"The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis","volume":"29","author":"Silva de Lima","year":"1999","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011006.pub2-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001130","article-title":"Drugs versus placebo for dysthymia","author":"Silva de Lima","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0130|cit130","first-page":"479","article-title":"Depression among medically ill patients","volume":"26","author":"Stewart","year":"1965","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"252-60","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressants trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011006.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000030.pub2","article-title":"Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals","author":"Turner","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011006.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4088\/JCP.v64n1203","article-title":"Improving adherence to antidepressants: a systematic review of interventions","volume":"64","author":"Vergouwen","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD011006.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1017\/S0033291713001372","article-title":"Treatment of depression in adults with cancer: a systematic review of randomized controlled trials","volume":"44","author":"Walker","year":"2014","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011006.pub2-BIB0135|cit135","first-page":"561","article-title":"Effects of psychological interventions in cancer patients undergoing radiotherapy","volume":"19","author":"Wang","year":"2011","journal-title":"Chinese Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0136|cit136","doi-asserted-by":"crossref","unstructured":"Ware JB Brook RH Williams KN Stewart AL Davies-Avery A Conceptualisation and measurement of health for adults in the health insurance study Model of Health and Methodology 1980","DOI":"10.7249\/R2262.2"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36) 1: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0138|cit138","volume-title":"The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)","author":"WHO","year":"1978"},{"key":"10.1002\/14651858.CD011006.pub2-BIB0139|cit139","volume-title":"The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)","author":"WHO","year":"1992"},{"issue":"7","key":"10.1002\/14651858.CD011006.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Losing participants before the trial ends erodes credibility of findings","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD011006.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD011006.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011006","article-title":"Antidepressants for the treatment of depression in patients with cancer","author":"Ostuzzi","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011006.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011006.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T09:54:31Z","timestamp":1652176471000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011006.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":142,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011006.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,1]]}}}